Texas Cardiac Arrhythmia Institute physician led international... - 27 October 2022 01:49

AUSTIN, Texas, Oct. 26, 2022 /PRNewswire-AsiaNet/ -- The executive medical director of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center ( https://c212.net/c/link/?t=0&l=en&o=3688951-1&h=30632352&u=https%3A%2F%2Ftcainstitute.com%2F&a=Texas+Cardiac+Arrhythmia+Institute+(TCAI...

  The future you desire. The life of your dreams. See it, feel i... - 27 October 2022 00:01

Sydney, Oct. 27, 2022/Medianet International-AsiaNet/ -- The first of its kind and totally unique – Lifeboard VR is a ground-breaking new manifestation platform to help users bring to reality their dreams and goals. It's time to enter a fully immersive virtual reality world where you can customize yo...

  OMRON Invests in Kirin Techno-System, Comprehensive Manufactur... - 26 October 2022 17:00

KYOTO, Japan, Oct. 26, 2022 /Kyodo JBN-AsiaNet/ -- - To Supply Safe and Secure Beverages and to Further Accelerate Global Environmental Conservation - OMRON Corporation (hereinafter "OMRON"), headquartered in Kyoto, and Kirin Brewery Company, Limited (hereinafter "Kirin Brewery"), a Tokyo-based...

  FDA Accepts NMP's Clinical Trial Application for Development o... - 25 October 2022 19:00

TOKYO, Oct. 25, 2022 /Kyodo JBN-AsiaNet/ -- - Clinical Study Set to Begin, Focusing on Diagnostic Use of Theranostics - Nihon Medi-Physics Co., Ltd. (NMP), a leading radiopharmaceutical company in Japan, is pleased to announce that the U.S. Food and Drug Administration (FDA) has recently...

  MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval - 25 October 2022 10:17

GENEVA, Oct. 25, 2022 /PRNewswire-AsiaNet/ -- Following our communication last week "MedAlliance to be acquired by Cordis", MedAlliance is pleased to make the following announcement: Photo - https://mma.prnewswire.com/media/1928464/MedAlliance_Image.jpg Logo - https://mma.prnewswire.com...

  T-cells treated by Turn Biotechnologies show increased cancer-... - 25 October 2022 02:30

MOUNTAIN VIEW, Calif., Oct. 25, 2022 /PRNewswire-AsiaNet/ -- - Preclinical data showing how ERA(TM), eTurna(TM) technologies turbocharge T-cell therapies presented at New Frontiers of RNA Nanotherapeutics meeting today - ERA(TM) boosts CAR T-cell efficacy by overcoming T-cell exhaustion that inhibits cance...

   deCODE genetics publishes multiomics study of nonalcoholic fa... - 25 October 2022 02:00

REYKJAVIK, Iceland Oct 24th, 2022 /PRNewswire-AsiaNet/ Scientists at deCODE genetics, a subsidiary of Amgen, publish today a large genome-wide association study on nonalcoholic fatty liver disease (NAFLD) in Nature Genetics. Sequence variants that associate with NAFLD were identified, including rar...

  SIRONA completes enrollment - A leap in the DCB treatment of f... - 22 October 2022 00:06

TAMPA, Fla., Oct. 21, 2022 /PRNewswire-AsiaNet/ -- Concept Medical Inc. [https://www.conceptmedical.com/] announces the successful completion of the SIRONA - World's first and the largest head-to-head RCT investigating the use of Sirolimus Drug Coated Balloon (DCB) (Magic Touch PTA [https://ww...

  On World Osteoporosis Day, take five steps to better bone health - 20 October 2022 22:00

NYON, Switzerland, Oct. 20, 2022, /PRNewswire-AsiaNet/-- Today, on World Osteoporosis Day, the International Osteoporosis Foundation (IOF) calls on people of all ages to be proactive in taking steps for better bone health and osteoporosis prevention. Osteoporosis is a bone disease that affects some...

  Alfasigma Acquires The Entire Share Capital Of Sofar, An Itali... - 20 October 2022 17:45

POMEZIA, Italy, Oct. 20, 2022 /PRNewswire-AsiaNet/ -- Alfasigma S.p.A. has completed the acquisition of SOFAR S.p.A., thus officially beginning the integrating process of the two companies. The transaction, which was launched last August and was scheduled for completion in October 2022, was succes...